CBT 📈 Cabot - Overview

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1270551013

CBT: Rubber, Carbon, Silica, Alumina, Aerogel, Masterbatch, Inkjet

Cabot Corporation is a specialty chemicals and performance materials company that operates through two primary segments: Reinforcement Materials and Performance Chemicals. The company's product portfolio is diverse, with a focus on delivering high-performance materials that enhance the properties of various products. For instance, its reinforcing carbons are used in the production of tires, where they serve as a rubber reinforcing agent and performance additive, while also being utilized in industrial products such as hoses, belts, and molded goods. Additionally, the company offers engineered elastomer composites solutions, which cater to the needs of various industries.

The company's specialty carbons find applications in a wide range of products, including inks, coatings, plastics, adhesives, toners, batteries, and displays. Furthermore, Cabot Corporation provides conductive additives and fumed alumina, which are used in the production of lead acid and lithium-ion batteries for electric vehicles. Its fumed silica is another key product, used in adhesives, sealants, cosmetics, batteries, inks, toners, silicone elastomers, coatings, polishing slurries, and pharmaceuticals. The company also offers fumed alumina for use in various products, such as inkjet media, lighting, coatings, cosmetics, and polishing slurries, demonstrating the versatility of its product offerings.

Cabot Corporation's product range extends to include aerogel, a hydrophobic, silica-based particle used in thermal insulation and specialty chemical applications. The company also manufactures masterbatch and conductive compound products, which are utilized in a broad range of industries, including automotive, industrial, packaging, infrastructure, agriculture, consumer products, and electronics. Moreover, its inkjet colorants are designed for inkjet printing applications, while the company also produces carbon nanotubes and fumed metal oxides, highlighting its commitment to innovation and meeting the evolving needs of its customers.

In terms of its market reach, Cabot Corporation sells its products through a network of distributors and sales representatives, with a global presence spanning the Americas, Europe, the Middle East, Africa, and the Asia Pacific. With a rich history dating back to 1882, the company is headquartered in Boston, Massachusetts, and has established itself as a leading player in the specialty chemicals and performance materials industry. As a publicly traded company listed on the New York Stock Exchange (NYSE) under the ticker symbol CBT, Cabot Corporation is committed to delivering value to its shareholders while maintaining its focus on innovation and customer satisfaction.

Additional Sources for CBT Stock

CBT Stock Overview

Market Cap in USD 5,963m
Sector Basic Materials
Industry Specialty Chemicals
GiC Sub-Industry Commodity Chemicals
IPO / Inception 1980-11-05

CBT Stock Ratings

Growth 5y 83.0%
Fundamental 71.1%
Dividend 56.4%
Rel. Strength Industry 745
Analysts 3.6/5
Fair Price Momentum 90.54 USD
Fair Price DCF 214.51 USD

CBT Dividends

Dividend Yield 12m 1.82%
Yield on Cost 5y 4.05%
Annual Growth 5y 2.61%
Payout Consistency 92.4%

CBT Growth Ratios

Growth Correlation 3m -66.8%
Growth Correlation 12m 85%
Growth Correlation 5y 95.1%
CAGR 5y 17.27%
CAGR/Mean DD 5y 1.58
Sharpe Ratio 12m 0.34
Alpha -24.01
Beta 1.31
Volatility 31.59%
Current Volume 212.1k
Average Volume 20d 414.6k
What is the price of CBT stocks?
As of December 27, 2024, the stock is trading at USD 92.74 with a total of 212,100 shares traded.
Over the past week, the price has changed by -0.08%, over one month by -15.81%, over three months by -16.59% and over the past year by +9.35%.
Is Cabot a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Cabot (NYSE:CBT) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 71.09 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CBT as of December 2024 is 90.54. This means that CBT is currently overvalued and has a potential downside of -2.37%.
Is CBT a buy, sell or hold?
Cabot has received a consensus analysts rating of 3.60. Therefor, it is recommend to hold CBT.
  • Strong Buy: 2
  • Buy: 0
  • Hold: 2
  • Sell: 1
  • Strong Sell: 0
What are the forecast for CBT stock price target?
According to ValueRays Forecast Model, CBT Cabot will be worth about 100.5 in December 2025. The stock is currently trading at 92.74. This means that the stock has a potential upside of +8.41%.
Issuer Forecast Upside
Wallstreet Target Price 117.6 26.8%
Analysts Target Price 85.4 -7.9%
ValueRay Target Price 100.5 8.4%